We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

115 hedge funds and large institutions have $74.7M invested in Sanofi Contingent Value Rights in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more capital inflows, than outflows

Capital inflows: $8.23M | Capital outflows: $7.21M

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

2% less funds holding

Funds holding: 117 → 115 (-2)

26% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 19

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
115
Holders Change
-2
Holders Change %
-1.71%
% of All Funds
3.05%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
7
Increased
14
Reduced
19
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

GCVRZ Hedge Fund Activity: Q1 2015 in Review

115 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2015, worth a combined $74.7M — down 12% from $85.2M a quarter earlier.

Fund positioning in GCVRZ was balanced in Q1 2015: 7 funds opened new positions, 7 closed out, 14 added to existing stakes and 19 trimmed.

The largest buyer was Elliott Management, opening a new position worth an estimated $6.02M. The largest seller was Whitebox Advisors, cutting an estimated $5.92M.

  • 115 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2015, down from 117 in Q4 2014.
  • Funds reported $74.7M of Sanofi Contingent Value Rights stock for Q1 2015, down 12% quarter-over-quarter.
  • 7 funds opened new Sanofi Contingent Value Rights positions in Q1 2015 and 7 closed out, a net change of 0 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2015 was Elliott Management, an estimated $6.02M added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2015 was Whitebox Advisors, an estimated $5.92M sold.

Based on aggregated 13F filings for Q1 2015.